Wang, H.-C.; Yeh, T.-J.; Chan, L.-P.; Hsu, C.-M.; Cho, S.-F.
Exploration of Feasible Immune Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma Treatment in Real World Clinical Practice. Int. J. Mol. Sci. 2020, 21, 7621.
https://doi.org/10.3390/ijms21207621
AMA Style
Wang H-C, Yeh T-J, Chan L-P, Hsu C-M, Cho S-F.
Exploration of Feasible Immune Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma Treatment in Real World Clinical Practice. International Journal of Molecular Sciences. 2020; 21(20):7621.
https://doi.org/10.3390/ijms21207621
Chicago/Turabian Style
Wang, Hui-Ching, Tsung-Jang Yeh, Leong-Perng Chan, Chin-Mu Hsu, and Shih-Feng Cho.
2020. "Exploration of Feasible Immune Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma Treatment in Real World Clinical Practice" International Journal of Molecular Sciences 21, no. 20: 7621.
https://doi.org/10.3390/ijms21207621
APA Style
Wang, H.-C., Yeh, T.-J., Chan, L.-P., Hsu, C.-M., & Cho, S.-F.
(2020). Exploration of Feasible Immune Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma Treatment in Real World Clinical Practice. International Journal of Molecular Sciences, 21(20), 7621.
https://doi.org/10.3390/ijms21207621
